No retraction, correction or concern found when last checked on Oct 29, 2026.
Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016
The GBD 2016 Lifetime Risk of Stroke Collaborators
New England Journal of Medicine · 2018
Abstract
BACKGROUND: The lifetime risk of stroke has been calculated in a limited number of selected populations. We sought to estimate the lifetime risk of stroke at the regional, country, and global level using data from a comprehensive study of the prevalence of major diseases. METHODS: We used the Global Burden of Disease (GBD) Study 2016 estimates of stroke incidence and the competing risks of death from any cause other than stroke to calculate the cumulative lifetime risks of first stroke, ischemic stroke, or hemorrhagic stroke among adults 25 years of age or older. Estimates of the lifetime risks in the years 1990 and 2016 were compared. Countries were categorized into quintiles of the sociodemographic index (SDI) used in the GBD Study, and the risks were compared across quintiles. Comparisons were made with the use of point estimates and uncertainty intervals representing the 2.5th and 97.5th percentiles around the estimate. RESULTS: The estimated global lifetime risk of stroke from the age of 25 years onward was 24.9% (95% uncertainty interval, 23.5 to 26.2); the risk among men was 24.7% (95% uncertainty interval, 23.3 to 26.0), and the risk among women was 25.1% (95% uncertainty interval, 23.7 to 26.5). The risk of ischemic stroke was 18.3%, and the risk of hemorrhagic stroke was 8.2%. In high-SDI, high-middle-SDI, and low-SDI countries, the estimated lifetime risk of stroke was 23.5%, 31.1% (highest risk), and 13.2% (lowest risk), respectively; the 95% uncertainty intervals did not overlap between these categories. The highest estimated lifetime risks of stroke according to GBD region were in East Asia (38.8%), Central Europe (31.7%), and Eastern Europe (31.6%), and the lowest risk was in eastern sub-Saharan Africa (11.8%). The mean global lifetime risk of stroke increased from 22.8% in 1990 to 24.9% in 2016, a relative increase of 8.9% (95% uncertainty interval, 6.2 to 11.5); the competing risk of death from any cause other than stroke was considered in this calculation. CONCLUSIONS: In 2016, the global lifetime risk of stroke from the age of 25 years onward was approximately 25% among both men and women. There was geographic variation in the lifetime risk of stroke, with the highest risks in East Asia, Central Europe, and Eastern Europe. (Funded by the Bill and Melinda Gates Foundation.).
Shown for reading. Its publisher allows quoting it, not republishing it.
References 20
- 1.
- 2.
- 3.
Feigin VL, Krishnamurthi RV, Parmar P, Norrving B, Mensah GA, Bennett DA, et al. Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study. Neuroepidemiology. 2015;45:161-176
Not in our library10.1159/000441085
- 4.
Feigin VL, Roth GA, Naghavi M, Parmar P, Krishnamurthi R, Chugh S, et al. Global burden of stroke and risk factors in 188 countries, during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. Neurology. 2016;15:913-924
Not in our library10.1016/s1474-4422(16)30073-4
- 5.
Lloyd-Jones DM, Larson MG, Beiser A, Levy D. Lifetime risk of developing coronary heart disease. Lancet. 1999;353:89-92
Not in our library10.1016/s0140-6736(98)10279-9
- 6.
Seshadri S, Wolf PA. Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study. Lancet Neurology. 2007;6:1106-1114
Not in our library10.1016/s1474-4422(07)70291-0
- 7.
Wang Y, Liu J, Wang W, Wang M, Qi Y, Xie W, et al. Lifetime risk of stroke in youngaged and middle-aged Chinese population: the Chinese Multi-Provincial Cohort Study. Journal of hypertension. 2016;34:2434-2440
Not in our library10.1097/hjh.0000000000001084
- 8.
Turin TC, Kokubo Y, Murakami Y, Higashiyama A, Rumana N, Watanabe M, et al. Lifetime risk of stroke in Japan. Stroke. 2010;41:1552-1554
Not in our library10.1161/strokeaha.110.581363
- 9.
Leening MJG, Ferket BS, Steyerberg EW, Kavousi M, Deckers JW, Nieboer D, et al. Sex differences in lifetime risk and first manifestation of cardiovascular disease: Prospective population based cohort study. BMJ (Online). 2014;349
Not in our library10.1136/bmj.g5992
- 10.
Berry JD, Dyer A, Cai X, Garside DB, Ning H, Thomas A, et al. Lifetime risks of cardiovascular disease. New Engl. J. Med. 2012;366:321-329
Not in our library10.1056/nejmoa1012848
- 11.
Turin TC, Okamura T, Afzal AR, Rumana N, Watanabe M, Higashiyama A, et al. Hypertension and lifetime risk of stroke. Journal of hypertension. 2016;34:116-122
Not in our library10.1097/hjh.0000000000000753
- 12.
Takahashi I, Geyer SM, Nishi N, Ohshita T, Takahashi T, Akahoshi M, et al. Lifetime risk of stroke and impact of hypertension: Estimates from the adult health study in Hiroshima and Nagasaki. Hypertension Research. 2011;34:649-654
Not in our library10.1038/hr.2011.7
- 13.
Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. The Lancet Neurology. 2009;8:355-369
Not in our library10.1016/s1474-4422(09)70025-0
- 14.
- 15.
Global Burden of Disease Study 2015. Global Burden of Disease Study 2015 (GBD 2015) Socio-Demographic Index (SDI) 1980–2015. Seattle, United States: Institute for Health Metrics and Evaluation (IHME); 2016.
Not in our library
- 16.
Human development report 2009: overcoming barriers—human mobility and development. New York: United Nations; 2009.
Not in our library
- 17.
Feigin VL, Norrving B, Mensah GA. Global Burden of Stroke. Circulation Research. 2017;120:439-448
Not in our library10.1161/circresaha.116.308413
- 18.
Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Au R, Kannel WB, et al. The lifetime risk of stroke: estimates from the Framingham Study. Stroke. 2006;37:345-350
Not in our library10.1161/01.str.0000199613.38911.b2
- 19.
Zhao D, Liu J, Wang W, Zeng Z, Cheng J, Liu J, et al. Epidemiological transition of stroke in China: twenty-one-year observational study from the Sino-MONICABeijing Project. Stroke. 2008;39:1668-1674
Not in our library10.1161/strokeaha.107.502807
- 20.
Cited by papers we hold 23
- Improving Access to Primordial and Primary Stroke Prevention: Global Considerations · 2025Not checked
- Alzheimer’s disease: insights into pathology, molecular mechanisms, and therapy · 2024No notice
- Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases · 2023No notice
- Estimated Burden of Stroke in China in 2020 · 2023No notice
- Anti-CHAC1 exosomes for nose-to-brain delivery of miR-760-3p in cerebral ischemia/reperfusion injury mice inhibiting neuron ferroptosis · 2023No notice
- Comparative study of extracellular vesicles derived from mesenchymal stem cells and brain endothelial cells attenuating blood–brain barrier permeability via regulating Caveolin-1-dependent ZO-1 and Claudin-5 endocytosis in acute ischemic stroke · 2023No notice
- Effectiveness of Using Virtual Reality–Supported Exercise Therapy for Upper Extremity Motor Rehabilitation in Patients With Stroke: Systematic Review and Meta-analysis of Randomized Controlled Trials · 2022No notice
- Myeloperoxidase: a new target for the treatment of stroke? · 2022Not checked
- Nitrate Metabolism and Ischemic Cerebrovascular Disease: A Narrative Review · 2022Not checked
- Patient and public involvement in stroke research: a scoping review protocol [version 2; peer review: 2 approved] · 2022Not checked
- DNA methylation signature of chronic low-grade inflammation and its role in cardio-respiratory diseases · 2022No notice
- Primary stroke prevention worldwide: translating evidence into action · 2022Corrected
- Role of Endogenous Lipopolysaccharides in Neurological Disorders · 2022No notice
- Thrombin induces ACSL4-dependent ferroptosis during cerebral ischemia/reperfusion · 2022No notice
- Diabetes Mellitus, Glycemic Traits, and Cerebrovascular Disease · 2021No notice
- Two-Year Outcome From Combining Cryoballoon Ablation and Left Atrial Appendage Closure: CLACBAC Study · 2021Not checked
- Influence of mobility restrictions on post‐stroke pain · 2021Not checked
- Age-related immune alterations and cerebrovascular inflammation · 2021No notice
- Neuroinflammation as a Key Driver of Secondary Neurodegeneration Following Stroke? · 2021No notice
- Human umbilical cord mesenchymal stem cell-derived exosomal miR-146a-5p reduces microglial-mediated neuroinflammation via suppression of the IRAK1/TRAF6 signaling pathway after ischemic stroke · 2021No notice
and 3 more
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.